The FDA has released its list of drugs that are being reviewed for safety problems. These drugs include gadolinium-based contrast agents, which are used during magnetic resonance imaging. 

The FDA is investigating these drugs for potential links to anaphylaxis hypersensitivity. The drugs have already been linked to Nephrogenic Systemic Fibrosis and Nephrogenic Fibrosing Dermopathy. 

If you or anyone you know has received a gadolinium-based contrast agent, contact the NSF and NFD lawyers of Williams Kherkher at 800-761-3187.

While the Food and Drug Administration (FDA) identified a link between gadolinium-based contrast agents and nephrogenic systemic fibrosis, the FDA has taken very few actions to prevent the use of the contrast agent in MRI scans. 

Because these contrast agents are still used in some MRI scans, it is important to be able to identify when gadolinium-based contrast agents are used in MRIs. The five most common types of these contrast agents are Magnevist, MultiHance, Omniscan, OptiMARK, and Prohance.

If you have received an MRI with a gadolinium-based contrast agent, contact the NSF and NSD lawyers of Williams Kherkher at 800-761-3187.

According to a study published in the American Roentgen Ray Society, exposure to gadolinium and other contrast agents can lead to adverse effects. While the rate of incidence is low, the study confirms the potential danger of these contrast agents. While most of the injuries caused by exposure are mild and can be treated, some are more serious and require serious medical attention.

The study was conducted by three researchers from the Mayo Clinic's Department of Radiology. The paper was titled "Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses." 

If you or anyone you know has been exposed to gadolinium and has suffered adverse effects, contact the NSF and NSD lawyers of Williams & Kherkher 800-761-3187.

Gadolinium is one of many metals being used in high-tech devices. These types of metals, which are heavily mined in China, are commonly known as rare-earth metals. 

Other types of rare-earth metals include cerium, samarium, europium, erbium, and thulium, among others. These metals are often used in products like magnets for cars, wind turbines, computer monitors, and televisions. 

Although these metals have helped engineer many technological breakthroughs, some can have harmful side effects. Among those is gadolinium, which is used as a contrast agent in MRIs and may lead to Nephrogenic Systemic Fibrosis (NSF) and Nephrogenic Fibrosing Dermopathy (NFD).

If you have been exposed to gadolinium, contact the NSF and NSF lawyers of Williams and Kherkher at 800-761-3187.

Although some doctors and other health officials doubt the link between Nephrogenic Systemic Firbrosis (NSF) and MRI testing with gadolinium, many doctos believe the link exists and have even gone as far to state that it may go beyond causing kidney failure. 

Many doctors main worry is that people who have received MRIs could be developing NSF without knowing it. In such cases, the damage caused by NSF could be life-threatening, affecting organs other than the kidneys. 

Some doctors suggest that any patient who has received gadolinium see their local doctor for the appropriate tests. 

If you or anyone you know has questions about NSF, contact the NSF and NSD lawyers of Williams and Kherkher at 800-761-3187.

The Federal Drug Administration (FDA) has approved gadolinium for use as a contrast agent in Magnetic Resonance Imaging (MRI). As a contrast agent, gadolinium allows MRIs to generate a clearer picture of the body’s organs and tissues.

Although MRIs can be performed without the contrast agent, the use of contrast agents allows doctors to better diagnose patients. Currently, gadolinium is the only FDA-approved contrast agent.

Gadolinium has been cited as the potential cause for patients contracting Nephrogenic Systemic Fibrosis (NSF), when the patient underwent an MRI that used gadolinium. Currently, the FDA has not established an official causal link between gadolinium and NSF, but is currently doing research to evaluate whether a causal link exists.

If you or anyone you know suffers from NSF and underwent an MRI with the gadolinium-contrast agent, please contact the NSF lawyers of Williams Kherkher at 800-761-3187.